SCHEMBL10205352

SCHEMBL10205352

Cc1ccc2c(-c3ccc(NC(=O)OC(C)C)cc3)c3ccc(=O)cc-3oc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.47
▸ USP2 O75604 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ ATM Q13315 1/20 0.47
▸ PLEC Q15149 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.45
▸ AGPAT2 O15120 1/20 0.43
▸ ALPL P05186 1/20 0.43
▸ ALPI P09923 1/20 0.43
▸ ALPG P10696 1/20 0.43
▸ THRB P10828 1/20 0.42
▸ CA1 P00915 2/20 0.40
▸ CA2 P00918 2/20 0.40
▸ CA9 Q16790 2/20 0.40
▸ CA12 O43570 1/20 0.40
▸ MMP12 P39900 1/20 0.39
▸ MMP13 P45452 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13932610 0.87 CA9 (0.52) USP2KDM4EAGPAT2CA1CA2
SCHEMBL17833665 0.81 MEN1 (0.49) POLBUSP2MEN1KMT2AATM
SCHEMBL18633954 0.77 CA9 (0.63) POLBUSP2MEN1KMT2AALPL
SCHEMBL9910747 0.76 MEN1 (0.72) POLBUSP2MEN1KMT2AATM
SCHEMBL14044262 0.74 USP2 (0.77) POLBUSP2MEN1KMT2AATM
SCHEMBL10014172 0.72 CA9 (0.56) POLBUSP2MEN1KMT2AALPL
SCHEMBL17833664 0.71 USP2 (0.64) POLBUSP2MEN1KMT2AATM
SCHEMBL15483657 0.70 ABCB1 (0.62) POLBUSP2MEN1KMT2AATM
SCHEMBL16103947 0.70 USP2 (0.62) POLBUSP2MEN1KMT2AATM
SCHEMBL12637546 0.69 USP2 (0.57) POLBUSP2MEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170073359-A1 Optically-Detectable Enzyme Substrates and Their Method of Use MOLECULAR PROBES, INC. 2017-03-16 — — US disclosed
US-20160139135-A1 Optically-Detectable Enzyme Substrates and Their Method of Use LIFE TECHNOLOGIES CORP (US) 2016-05-19 — — US disclosed
US-8865891-B2 Optically-detectable enzyme substrates and their method of use Life Technologies Corporation (US) 2014-10-21 — — US disclosed
US-20130090470-A1 OPTICALLY-DETECTABLE ENZYME SUBSTRATES AND THEIR METHOD OF USE Life Technologies Corporation (US) 2013-04-11 — — US disclosed
US-8318450-B2 Optically-detectable enzyme substrates and their method of use Life Technologies Corporation (US) 2012-11-27 — — US disclosed
US-20120040380-A1 OPTICALLY-DETECTABLE ENZYME SUBSTRATES AND THEIR METHOD OF USE Life Technologies Corporation (US) 2012-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160139135-A1 Optically-Detectable Enzyme Substrates and Their Method of Use MGAM, LCT, GAA POLB 455/4885USP2 1435/4885MEN1 3638/4885
US-20170073359-A1 Optically-Detectable Enzyme Substrates and Their Method of Use MGAM, LCT, GAA POLB 455/4885USP2 1435/4885MEN1 3638/4885
US-20130090470-A1 OPTICALLY-DETECTABLE ENZYME SUBSTRATES AND THEIR METHOD OF USE MGAM, LCT, GAA POLB 455/4885USP2 1435/4885MEN1 3638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback